Ernst &Young’s annual Pulse of the Industry report says strong R&D spending by medtechs in 2019 bodes well for their post-pandemic recovery as industry leaders point to long-term changes to the industry that companies must navigate when future-proofing their business models.
Medtech companies looking to recover from the challenges of the global pandemic now face likely permanent changes to their business models, including supply chain management, collaborations, health care delivery, and digitalization as they futureproof operations against future disruption and plan effective deployment of limited capital resources.
This was one of the main conclusions of a 6 October industry leader panel at the recent AdvaMed Virtual Medtech...
Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.
Point of care ultrasound technology that can be used by non-sonographers will plug gaps in workforce coverage and bring new critical care capabilities to the frontline of care, said Royal Philips.
The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.
